Response to editorial by Richard Crevenna, MD, regarding "cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services" by Silver et al.

被引:1
|
作者
Silver, Julie K. [1 ]
Smith, Sean R. [2 ]
Wisotzky, Eric M. [3 ]
Raj, Vishwa S. [4 ]
Fu, Jack B. [5 ]
Kirch, Rebecca A. [6 ]
机构
[1] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Charlestown, MA 02129 USA
[2] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA
[3] MedStar Natl Rehabil Network, Washington, DC 20010 USA
[4] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Palliat Rehabil & Integrat Med, Houston, TX 77030 USA
[6] Amer Canc Soc, Washington, DC 20004 USA
关键词
Cancer rehabilitation; Palliative care; Prehabilitation; Quality of life; Supportive oncology; Survivorship;
D O I
10.1007/s00520-015-2917-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Palliative care and rehabilitation practitioners are important collaborative referral sources for each other who can work together to improve the lives of cancer patients, survivors, and caregivers by improving both quality of care and quality of life. Cancer rehabilitation and palliative care involve the delivery of important but underutilized medical services to oncology patients by interdisciplinary teams. These subspecialties are similar in many respects, including their focus on improving cancer-related symptoms or cancer treatment-related side effects, improving health-related quality of life, lessening caregiver burden, and valuing patient-centered care and shared decision-making. They also aim to improve healthcare efficiencies and minimize costs by means such as reducing hospital lengths of stay and unanticipated readmissions. Although their goals are often aligned, different specialized skills and approaches are used in the delivery of care. For example, while each specialty prioritizes goal-concordant care through identification of patient and family preferences and values, palliative care teams typically focus extensively on using patient and family communication to determine their goals of care, while also tending to comfort issues such as symptom management and spiritual concerns. Rehabilitation clinicians may tend to focus more specifically on functional issues such as identifying and treating deficits in physical, psychological, or cognitive impairments and any resulting disability and negative impact on quality of life. Additionally, although palliative care and rehabilitation practitioners are trained to diagnose and treat medically complex patients, rehabilitation clinicians also treat many patients with a single impairment and a low symptom burden. In these cases, the goal is often cure of the underlying neurologic or musculoskeletal condition. This report defines and describes cancer rehabilitation and palliative care, delineates their respective roles in comprehensive oncology care, and highlights how these services can contribute complementary components of essential quality care. An understanding of how cancer rehabilitation and palliative care are aligned in goal setting, but distinct in approach may help facilitate earlier integration of both into the oncology care continuum-supporting efforts to improve physical, psychological, cognitive, functional, and quality of life outcomes in patients and survivors.
引用
收藏
页码:3409 / 3410
页数:2
相关论文
共 2 条
  • [1] Response to editorial by Richard Crevenna, MD, regarding “cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services” by Silver et al.
    Julie K. Silver
    Sean R. Smith
    Eric M. Wisotzky
    Vishwa S. Raj
    Jack B. Fu
    Rebecca A. Kirch
    [J]. Supportive Care in Cancer, 2015, 23 : 3409 - 3410
  • [2] Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services
    Julie K. Silver
    Vishwa S. Raj
    Jack B. Fu
    Eric M. Wisotzky
    Sean Robinson Smith
    Rebecca A. Kirch
    [J]. Supportive Care in Cancer, 2015, 23 : 3633 - 3643